Klenerman develops and applies single-molecule fluorescence and scanning-probe methods (including nanopipette scanning ion-conductance microscopy and a single-objective oblique-plane light-sheet microscope) to study protein misfolding and aggregation in neurodegenerative disease, alongside his earlier work co-inventing next-generation DNA sequencing.